[A Review of the State of Purinergic Signaling and Psychological Stress].
ATP
Adenosine
Psychological stress
Purinergic receptor
Purinergic signaling
Journal
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
ISSN: 1672-173X
Titre abrégé: Sichuan Da Xue Xue Bao Yi Xue Ban
Pays: China
ID NLM: 101162609
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
entrez:
21
1
2021
pubmed:
22
1
2021
medline:
23
1
2021
Statut:
ppublish
Résumé
Purinergic signaling is involved in multiple physiological and pathological processes. Psychological stress, as an inharmonious state in response to stressors, is closely related to the function or dysfunction of purinergic signaling. Abnormal expression of ATP interceptors caused by stress leads to psychological stress-related diseases, such as anxiety, depression, post-traumatic stress disorder and schizophrenia. Recent studies demonstrate that a complex network of purinergic signaling (such as ATP, adenosine and P2X2R, P2X3R, P2X4R, P2X7R, A1R, A2AR) plays a key role in psychological stress, but the specific mechanism remains to be further studied. And few studies focus on the application of ATP real-time detecting to psychological stress animal models, so the specific biological role of ATP in the process of stress is still unknown. This review will summarize the relationship between purinergic signaling and psychological stress and propose to apply the duplicate ATP real-time detection technology and purinergic compounds on psychological stress research in order to provide novel potential targets for the treatment of stress-related diseases.
Identifiants
pubmed: 33474886
doi: 10.12182/20210160102
pmc: PMC10408934
doi:
Types de publication
Journal Article
Review
Langues
chi
Sous-ensembles de citation
IM
Pagination
33-38Informations de copyright
Copyright© by Editorial Board of Journal of Sichuan University (Medical Sciences).
Références
Biochem Pharmacol. 2018 May;151:157-165
pubmed: 28735873
Psychoneuroendocrinology. 2019 Oct;108:182-189
pubmed: 31248747
Nat Med. 2013 Jun;19(6):773-7
pubmed: 23644515
Brain Behav Immun. 2017 Nov;66:302-312
pubmed: 28751018
Neurobiol Stress. 2015 Jan 1;1:174-183
pubmed: 25729760
Purinergic Signal. 2019 Dec;15(4):477-489
pubmed: 31576486
Psychoneuroendocrinology. 2018 Nov;97:120-130
pubmed: 30015007
Purinergic Signal. 2020 Mar;16(1):73-84
pubmed: 32067141
J Theor Biol. 1976 Oct 21;62(2):491-503
pubmed: 994531
Purinergic Signal. 2019 Dec;15(4):451-463
pubmed: 31478181
Pharmacol Rev. 2001 Dec;53(4):527-52
pubmed: 11734617
Neurochem Res. 2011 Oct;36(10):1876-86
pubmed: 21603935
Purinergic Signal. 2019 Dec;15(4):423-438
pubmed: 31493132
Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7833-8
pubmed: 26056314
Neuropsychopharmacology. 2003 Mar;28(3):435-44
pubmed: 12629523
J Neurochem. 1979 Nov;33(5):999-1005
pubmed: 228008
Purinergic Signal. 2020 Mar;16(1):17-28
pubmed: 31823189
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:117-31
pubmed: 25445063
Biol Psychiatry. 2016 Jul 1;80(1):12-22
pubmed: 26831917
Neuropharmacology. 2016 May;104:212-25
pubmed: 26518371
Purinergic Signal. 2017 Jun;13(2):153-170
pubmed: 27858314
Purinergic Signal. 2020 Jun;16(2):167-174
pubmed: 32236790
Proc Natl Acad Sci U S A. 1980 May;77(5):2551-4
pubmed: 6248853
Epilepsy Behav. 2018 Sep;86:173-178
pubmed: 30017837
Nat Rev Drug Discov. 2008 Jul;7(7):575-90
pubmed: 18591979
Neurosci Bull. 2020 Nov;36(11):1271-1280
pubmed: 32909219
Vascul Pharmacol. 2015 Dec;75:1-6
pubmed: 25989108
Neurosci Biobehav Rev. 2018 Apr;87:192-205
pubmed: 29453990
Biol Psychiatry. 2015 Dec 1;78(11):763-74
pubmed: 25869810
Neuropharmacology. 2016 May;104:31-49
pubmed: 26686393
Trends Neurosci. 2009 Jan;32(1):19-29
pubmed: 19008000
Int J Neuropsychopharmacol. 2013 Jun;16(5):1059-70
pubmed: 23174033
Brain Behav Immun. 2014 Nov;42:69-80
pubmed: 24989856
Acta Biochim Pol. 2016;63(1):1-9
pubmed: 26495439
Biochim Biophys Acta. 2011 May;1808(5):1380-99
pubmed: 21145878
JAMA. 1992 Mar 4;267(9):1244-52
pubmed: 1538563
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5113-7
pubmed: 7685114
Neuropharmacology. 2015 Feb;89:64-76
pubmed: 25220030
Pharmacol Rev. 1972 Sep;24(3):509-81
pubmed: 4404211
ACS Chem Neurosci. 2020 Dec 16;11(24):4387-4397
pubmed: 33284579
Nature. 1994 Oct 6;371(6497):519-23
pubmed: 7523952
Brain Res Bull. 2019 Sep;151:153-163
pubmed: 30593878
J Nucl Med. 2015 Oct;56(10):1527-33
pubmed: 26205303
Neuron. 2015 Aug 5;87(3):549-62
pubmed: 26247862
Mol Neurobiol. 2016 May;53(4):2518-28
pubmed: 26081145
Gen Pharmacol. 1985;16(5):433-40
pubmed: 2996968
Neuropharmacology. 2018 Jan;128:474-481
pubmed: 28802645
Mol Neuropsychiatry. 2020 Apr;5(Suppl 1):44-59
pubmed: 32399469
Methods Mol Biol. 2020;2041:1-15
pubmed: 31646477